WO2007110649A3 - Process for the preparation of 2,6,9-trisubstituted purines - Google Patents

Process for the preparation of 2,6,9-trisubstituted purines Download PDF

Info

Publication number
WO2007110649A3
WO2007110649A3 PCT/GB2007/001140 GB2007001140W WO2007110649A3 WO 2007110649 A3 WO2007110649 A3 WO 2007110649A3 GB 2007001140 W GB2007001140 W GB 2007001140W WO 2007110649 A3 WO2007110649 A3 WO 2007110649A3
Authority
WO
WIPO (PCT)
Prior art keywords
alkyl
compound
formula
aryl
aralkyl
Prior art date
Application number
PCT/GB2007/001140
Other languages
French (fr)
Other versions
WO2007110649A2 (en
Inventor
Robert Westwood
Gavin Wood
Jonathan Charles Chri Atherton
Original Assignee
Cyclacel Ltd
Robert Westwood
Gavin Wood
Jonathan Charles Chri Atherton
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cyclacel Ltd, Robert Westwood, Gavin Wood, Jonathan Charles Chri Atherton filed Critical Cyclacel Ltd
Priority to EP07732194A priority Critical patent/EP2010533A2/en
Publication of WO2007110649A2 publication Critical patent/WO2007110649A2/en
Publication of WO2007110649A3 publication Critical patent/WO2007110649A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/16Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Abstract

The present invention relates to a process for preparing a compound of formula (I), or a pharmaceutically acceptable salt thereof, wherein R2 is (a) where R3, R4, R7 and R8 are each independently selected from H, alkyl, aryl and aralkyl, said alkyl, aryl and aralkyl groups each being optionally substituted with one or more R12 groups, and wherein at least one of R3, R4, R7 and R8 is other than H; R5 is OH, O-alkyl, NH2, H, alkyl, aryl or aralkyl, said alkyl, aryl and aralkyl groups each being optionally substituted with one or more R12 groups; R6 is NR10R11, wherein R10 and R11 are each independently H or hydrocarbyl; R9 is hydrocarbyl; and each R12 is independently selected from OR13, halo, alkyl, COOR14, CONR15R16, SO2NR17R18, NO2, CN, NR19R20SR21 and CF3, where R13-21 are each independently H, alkyl or aryl; said process comprising the steps of (II) (III) (IV) (i) converting a compound of formula (II) to a compound of formula (III), wherein X is halo and R is aryl, alkyl, cycloalkyl, aralkyl, heteroaryl or alkyl-heteroaryl; (ii) converting said compound of formula (III) to a compound of formula (IV); and (iii) converting said compound of formula (IV) to a compound of formula (I).
PCT/GB2007/001140 2006-03-29 2007-03-29 Process for the preparation of 2,6,9-trisubstituted purines WO2007110649A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP07732194A EP2010533A2 (en) 2006-03-29 2007-03-29 Process for the preparation of 2,6,9-trisubstituted purines

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0606283.0A GB0606283D0 (en) 2006-03-29 2006-03-29 Process
GB0606283.0 2006-03-29

Publications (2)

Publication Number Publication Date
WO2007110649A2 WO2007110649A2 (en) 2007-10-04
WO2007110649A3 true WO2007110649A3 (en) 2007-12-06

Family

ID=36424806

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2007/001140 WO2007110649A2 (en) 2006-03-29 2007-03-29 Process for the preparation of 2,6,9-trisubstituted purines

Country Status (3)

Country Link
EP (1) EP2010533A2 (en)
GB (1) GB0606283D0 (en)
WO (1) WO2007110649A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO2998B1 (en) 2010-06-04 2016-09-05 Amgen Inc Piperidinone derivatives as mdm2 inhibitors for the treatment of cancer
DK3054936T5 (en) 2013-10-10 2024-03-18 Eastern Virginia Medical School 4-((2-HYDROXY-3-METHOXYBENZYL)AMINO) BENZENESULFONAMIDE DERIVATIVES AS 12-LIPOXYGENASE INHIBITORS

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998005335A1 (en) * 1996-08-02 1998-02-12 Cv Therapeutics, Inc. PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND IλB-$g(a)
WO2004016613A2 (en) * 2002-08-15 2004-02-26 Cyclacel Limited Purine derivatives and their use as antiproliferative agents

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998005335A1 (en) * 1996-08-02 1998-02-12 Cv Therapeutics, Inc. PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND IλB-$g(a)
WO2004016613A2 (en) * 2002-08-15 2004-02-26 Cyclacel Limited Purine derivatives and their use as antiproliferative agents

Also Published As

Publication number Publication date
EP2010533A2 (en) 2009-01-07
WO2007110649A2 (en) 2007-10-04
GB0606283D0 (en) 2006-05-10

Similar Documents

Publication Publication Date Title
IL267606A (en) Compound and method of synthesizing same for the preparation of halichondrin b
WO2009041453A1 (en) Bicyclic γ-amino acid derivative
WO2008071918A8 (en) Pyrido-pyrazine derivatives useful as herbicidal compounds
WO2011117591A3 (en) Amine synergists and their use in radiation curing
WO2008126933A3 (en) Process for producing pesticidal benzamide compounds
MX2012012421A (en) Tetrahydrobenzothiophene compound.
MY157073A (en) Conversion method
WO2008096231A8 (en) Antiparasitic agents
AU2015221439B2 (en) Crystalline 6,7-unsaturated-7-carbamoyl morphinane derivative, and method for producing same
UA93424C2 (en) Preparation of azoxystrobin
WO2021183750A3 (en) Methods of preparing 1'-cyano nucleosides
UA99447C2 (en) Process for the preparation of sildenafil
PL1753712T3 (en) Amino-propanol derivatives
EA200800502A1 (en) 3-AMINOCARBAZOLE COMPOUNDS, PHARMACEUTICAL COMPOSITION CONTAINING THE INDICATED COMPOUNDS, AND METHOD FOR THEIR PRODUCTION
WO2010007318A3 (en) Imidazo [1, 2-a] pyrimidine derivatives method for the production thereof application thereof as medicaments pharmaceutical compositions and use thereof as met inhibitors
EP1279665A3 (en) A process for the preparation of perindopril, its analogous compounds and salts thereof using 2,5-dioxo-oxazolidine intermediate compounds
WO2008136512A1 (en) Separating agent for optical isomer
WO2014017938A3 (en) Process for the synthesis of substituted urea compounds
WO2009083532A3 (en) Novel method for the preparation of derivatives of dihydrotetraazapentacenes, products such as obtained, and uses thereof
WO2007110649A3 (en) Process for the preparation of 2,6,9-trisubstituted purines
ATE425204T1 (en) METHOD FOR MODIFYING A MACROMOLECULAR SYSTEM
WO2003051848A3 (en) Imidazolidineacetic acid derivatives
SG149005A1 (en) Process for the preparation of thiazolopyrimidines
UA97388C2 (en) Antiparasitic agents
IL186979A0 (en) A process for the preparation of pyridine-methylsulfinyl compounds

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 2007732194

Country of ref document: EP

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07732194

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE